UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detection of N-glycolyl-neuraminic acid-containing glycolipids in human skin

Frontiers in immunology, 2023-11, Vol.14, p.1291292-1291292

2023

Volltextzugriff (PDF)

A Role for cis Interaction between the Inhibitory Ly49A Receptor and MHC Class I for Natural Killer Cell Education

Immunity (Cambridge, Mass.), 2009-03, Vol.30 (3), p.337-347

2009

Volltextzugriff (PDF)

Distinct Conformations of Ly49 Natural Killer Cell Receptors Mediate MHC Class I Recognition in Trans and Cis

Immunity (Cambridge, Mass.), 2009-10, Vol.31 (4), p.598-608

2009

Volltextzugriff (PDF)

PU.1 determines the self-renewal capacity of erythroid progenitor cells

Blood, 2004-05, Vol.103 (10), p.3615-3623

2004

Volltextzugriff (PDF)

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

Journal of allergy and clinical immunology, 2019-08, Vol.144 (2), p.482-493.e7

2019

Volltextzugriff (PDF)

Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact

Proceedings of the National Academy of Sciences - PNAS, 2007-03, Vol.104 (10), p.3978-3983

2007

Volltextzugriff (PDF)

Emergency Department Escalation in Theory and Practice: A Mixed-Methods Study Using a Model of Organizational Resilience

Annals of emergency medicine, 2017-11, Vol.70 (5), p.659-671

2017

Volltextzugriff (PDF)

The Health Services Safety Investigations Body (HSSIB) and safety management systems: An integrated approach to managing safety in healthcare

Journal of patient safety and risk management, 2024-03, Vol.29 (2), p.79-82

2024

Volltextzugriff (PDF)

A resilience markers framework for small teams

Reliability engineering & system safety, 2011, Vol.96 (1), p.2-10

2011

Volltextzugriff (PDF)

National Early Warning Score 2 (NEWS2) to identify inpatient COVID-19 deterioration: a retrospective analysis

Clinical medicine (London, England), 2021-03, Vol.21 (2), p.84-89

2021

Volltextzugriff (PDF)

GBR1302: Effect of CD3-HER2, a bispecific T cell engager antibody, in trastuzumab-resistant cancers

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.12053-12053

2018

Volltextzugriff (PDF)

Education of murine NK cells requires both cis and trans recognition of MHC class I molecules

The Journal of immunology (1950), 2013-11, Vol.191 (10), p.5044-5051

2013

Volltextzugriff (PDF)

An evaluation of relevancy ranking techniques used by internet search engines

Library and Information Research, 2013-06, Vol.24 (77), p.30-34

Back, Jonathan

2013

Volltextzugriff (PDF)

Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells

Journal of Crohn's and colitis, 2021-09, Vol.15 (9), p.1596-1601

2021

Volltextzugriff (PDF)

Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin

Blood, 2008-01, Vol.111 (1), p.142-149

2008

Volltextzugriff (PDF)

A phase I study of the bispecific antibody T-cell engager GBR 1302 in subjects with HER2-positive cancers

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS3091-TPS3091

2017

Volltextzugriff (PDF)

Phase 1, multicenter, open-label study of single-agent bispecific antibody t-cell engager GBR 1342 in relapsed/refractory multiple myeloma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS3132-TPS3132

2018

Volltextzugriff (PDF)

Recovering From an Interruption: Investigating Speed−Accuracy Trade-Offs in Task Resumption Behavior

Journal of experimental psychology. Applied, 2013-06, Vol.19 (2), p.95-107

2013

Volltextzugriff (PDF)

Phase 1, multicenter, open-label study of single-agent bispecific antibody T-cell engager GBR 1342 in relapsed/refractory multiple myeloma

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.TPS81-TPS81

2018

Volltextzugriff (PDF)

Preliminary biomarker and pharmacodynamic data from a phase I study of single-agent bispecific antibody T-cell engager GBR 1302 in subjects with HER2-positive cancers

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.69-69

2018

Volltextzugriff (PDF)

How external and internal resources influence user action: the case of infusion devices

Cognition, technology & work, 2016, Vol.18 (4), p.793-805

2016

Volltextzugriff (PDF)

The roles of conceptual device models and user goals in avoiding device initialization errors

Interacting with computers, 2010-09, Vol.22 (5), p.363-374

2010

Volltextzugriff (PDF)

Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses

Skin (Milwood, N.Y.), 2018-12, Vol.2, p.S62

2018

Volltextzugriff (PDF)

A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies

Journal of hematology and oncology, 2014-04, Vol.7 (1), p.33-33, Article 33

2014

Volltextzugriff (PDF)

Combining human error verification and timing analysis: a case study on an infusion pump

Formal aspects of computing, 2014-09, Vol.26 (5), p.1033-1076

2014

Volltextzugriff (PDF)

1 – 25 von 228

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(205)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(227)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Life Sciences & Biomedicine
(75)
Humans
(56)
Technology
(37)
Female
(30)
Male
(29)
Animals
(27)
Adult
(26)
Computer Science
(24)
Mice
(22)
Biological And Medical Sciences
(20)
Immunology
(18)
Middle Aged
(17)
Medical Sciences
(16)
Computer Science, Theory & Methods
(15)
Engineering
(14)
Science & Technology - Other Topics
(14)
Aged
(13)
Oncology
(13)
Physical Sciences
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Detection of N-glycolyl-neuraminic acid-containing glycolipids in human skin

A Role for cis Interaction between the Inhibitory Ly49A Receptor and MHC Class I for Natural Killer Cell Education

Distinct Conformations of Ly49 Natural Killer Cell Receptors Mediate MHC Class I Recognition in Trans and Cis

PU.1 determines the self-renewal capacity of erythroid progenitor cells

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact

Emergency Department Escalation in Theory and Practice: A Mixed-Methods Study Using a Model of Organizational Resilience

The Health Services Safety Investigations Body (HSSIB) and safety management systems: An integrated approach to managing safety in healthcare

A resilience markers framework for small teams

National Early Warning Score 2 (NEWS2) to identify inpatient COVID-19 deterioration: a retrospective analysis

GBR1302: Effect of CD3-HER2, a bispecific T cell engager antibody, in trastuzumab-resistant cancers

Education of murine NK cells requires both cis and trans recognition of MHC class I molecules

An evaluation of relevancy ranking techniques used by internet search engines

Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells

Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin

A phase I study of the bispecific antibody T-cell engager GBR 1302 in subjects with HER2-positive cancers

Phase 1, multicenter, open-label study of single-agent bispecific antibody t-cell engager GBR 1342 in relapsed/refractory multiple myeloma

Recovering From an Interruption: Investigating Speed−Accuracy Trade-Offs in Task Resumption Behavior

Phase 1, multicenter, open-label study of single-agent bispecific antibody T-cell engager GBR 1342 in relapsed/refractory multiple myeloma

Preliminary biomarker and pharmacodynamic data from a phase I study of single-agent bispecific antibody T-cell engager GBR 1302 in subjects with HER2-positive cancers

How external and internal resources influence user action: the case of infusion devices

The roles of conceptual device models and user goals in avoiding device initialization errors

Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses

A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies

Combining human error verification and timing analysis: a case study on an infusion pump

Suchergebnisse filtern